Abstract 3791: A prognostic signature based on inherited genetic polymorphisms for patients with uveal melanoma

黑色素瘤 医学 癌症 签名(拓扑) 肿瘤科 内科学 癌症研究 几何学 数学
作者
Thibault Verrier,Anne L. van de Ven,Alexandre Houy,Agathe Garcia,Gaëlle Pierron,Nathalie Cassoux,Manuel Rodrigues,Josselin Noirel,Marc‐Henri Stern
出处
期刊:Cancer Research [American Association for Cancer Research]
卷期号:84 (6_Supplement): 3791-3791
标识
DOI:10.1158/1538-7445.am2024-3791
摘要

Abstract Introduction: Uveal melanoma (UM) is the most frequent eye malignancy in adults. Two UM subtypes exist, defined by Gene Expression Profiling or by genomic status: GEP class 1/disomy 3 [D3] and GEP class 2/monosomy 3 [M3] defining low-risk or high-risk of developing metastasis, respectively. However, these prognostic signatures require tumor samples, which may be difficult to obtain. We previously identified by a genome-wide association study (GWAS) frequent single nucleotide polymorphisms (SNP) in IRF4 and HERC2 associated with risk for D3 or M3 UM, respectively (1). Here, we aim to design a prognostic signature for the D3 and M3 UM subtypes based on these constitutive polymorphisms, available from blood samples. Experimental Procedures: We used the GWAS cohort of 1476 UM patients genotyped on GSA or Omni5. Risk SNPs coupled with clinical variables were used on a cohort of 497 UM patients (191 D3, 306 M3) in a statistical machine learning process to define a predictive signature of UM subtype. A cohort of 852 UM patients was used for validation. Results: We retained two SNPs, rs12203592 (in IRF4) and rs12913832 (in HERC2), tumor diameter and thickness, age at diagnosis and gender. We validated the predictive model in the validation cohort. The predicted high-risk group showed a decrease in time to relapse (TR) (HR: 3.72 [2.57 - 5.41], logrank p-value = 1.35E-15), overall survival (OS) (HR: 3.85 [2.58 - 5.73], logrank p-value = 1.24E-14) and progression-free-survival (PFS) (HR: 3.61 [2.32 - 5.61], logrank p-value = 6.55E-11), compared with the predicted low-risk group. Conclusion: Common germline polymorphisms contribute to the prediction of metastatic risk in patients with localized uveal melanoma. This information could be especially useful when access to the tumor is problematic. 1. Mobuchon et al, J Natl Cancer Inst, 114, 2, (2022) Citation Format: Thibault Verrier, Anaïs Le Ven, Alexandre Houy, Agathe Garcia, Pierron Gaelle, Nathalie Cassoux, Manuel Rodrigues, Josselin Noirel, Marc-Henri Stern. A prognostic signature based on inherited genetic polymorphisms for patients with uveal melanoma [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 3791.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
哭泣藏花完成签到 ,获得积分10
1秒前
3秒前
含蓄的小熊猫完成签到 ,获得积分10
3秒前
3秒前
充电宝应助可耐的妙芙采纳,获得10
3秒前
66666完成签到 ,获得积分10
4秒前
4秒前
4秒前
刘纳完成签到 ,获得积分10
6秒前
lidada123发布了新的文献求助30
7秒前
9秒前
汉堡包应助Janus采纳,获得10
9秒前
9秒前
9秒前
伶俐雨双发布了新的文献求助10
10秒前
10秒前
王大王发布了新的文献求助10
11秒前
刘纳关注了科研通微信公众号
11秒前
明理归尘完成签到,获得积分10
11秒前
zcx发布了新的文献求助10
14秒前
15秒前
可耐的妙芙完成签到,获得积分20
15秒前
大气的寇发布了新的文献求助10
16秒前
顾瑶发布了新的文献求助10
16秒前
16秒前
Cmiudz发布了新的文献求助30
17秒前
tjxz2002关注了科研通微信公众号
18秒前
伶俐雨双完成签到,获得积分10
19秒前
宇宙发布了新的文献求助30
19秒前
dolla完成签到 ,获得积分10
20秒前
隐形曼青应助雪松采纳,获得10
21秒前
天马发布了新的文献求助10
21秒前
21秒前
21秒前
zcx完成签到,获得积分10
21秒前
zzp完成签到,获得积分10
21秒前
23秒前
王诣雯完成签到,获得积分10
23秒前
24秒前
唐茂铭完成签到,获得积分10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Fermented Coffee Market 2000
微纳米加工技术及其应用 500
Constitutional and Administrative Law 500
PARLOC2001: The update of loss containment data for offshore pipelines 500
Critical Thinking: Tools for Taking Charge of Your Learning and Your Life 4th Edition 500
Vertebrate Palaeontology, 5th Edition 420
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 纳米技术 计算机科学 内科学 化学工程 复合材料 物理化学 基因 遗传学 催化作用 冶金 量子力学 光电子学
热门帖子
关注 科研通微信公众号,转发送积分 5289842
求助须知:如何正确求助?哪些是违规求助? 4441315
关于积分的说明 13827119
捐赠科研通 4323763
什么是DOI,文献DOI怎么找? 2373344
邀请新用户注册赠送积分活动 1368758
关于科研通互助平台的介绍 1332673